CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Prepaid Assets of $223000.0 for Q4 2025, down 38.74% on a QoQ basis from $364000.0 in Q2 2025, and down 99.95% year-over-year from $433.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Prepaid Assets history runs 8 years deep, the most recent figure standing at $223000.0 for Q4 2025.
- Quarterly Prepaid Assets fell 99.95% year-over-year to $223000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $223000.0 (down 99.95% YoY) and the FY2025 annual result came in at $223000.0, down 99.95% from the prior year.
- Prepaid Assets was $223000.0 for Q4 2025 at CollPlant Biotechnologies, down from $364000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $424.0 billion in Q4 2021 and bottomed at $223000.0 in Q4 2025.
- A 5-year average of $23.7 billion and a median of $750500.0 in 2021 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets jumped 177405757.74% — and 2025, when it plunged 99.95%.
- CollPlant Biotechnologies' Prepaid Assets stood at $424.0 billion in 2021, then slumped by 99.87% to $543.0 million in 2022, then slumped by 99.93% to $393000.0 in 2023, then surged by 110078.12% to $433.0 million in 2024, then plunged by 99.95% to $223000.0 in 2025.
- Business Quant data shows CLGN's Prepaid Assets at $223000.0 in Q4 2025, $364000.0 in Q2 2025, and $433.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 223,000.00 |
| Jun 30, 2025 | 364,000.00 |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 426.00 Mn |
| Jun 30, 2024 | 490,000.00 |
| Mar 31, 2024 | 279.00 Mn |
| Dec 31, 2023 | 393,000.00 |
| Sep 30, 2023 | 493.00 Mn |
| Jun 30, 2023 | 758,000.00 |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 543.00 Mn |
| Sep 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 594,000.00 |
| Mar 31, 2022 | 263,000.00 |
| Dec 31, 2021 | 424.00 Bn |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 979,000.00 |
| Mar 31, 2021 | 267.00 Mn |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 550,000.00 |